News
CDMO
12.49
0.00%
0.00
Avid Bioservices Acquired by GHO and Ampersand Capital
TipRanks · 02/05/2025 17:19
AVID BIOSERVICES, INC. PROVIDES NOTICE OF FUNDAMENTAL CHANGE AND MAKE-WHOLE FUNDAMENTAL CHANGE TO HOLDERS OF ITS CONVERTIBLE NOTES IN CONNECTION WITH COMPLETED MERGER
Reuters · 02/05/2025 15:45
Press Release: Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger
Dow Jones · 02/05/2025 15:45
GHO Capital, Ampersand Capital announce closing of Avid Bioservices acquisition
TipRanks · 02/05/2025 15:01
Press Release: Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
Dow Jones · 02/05/2025 14:55
Weekly Report: what happened at CDMO last week (0127-0131)?
Weekly Report · 02/03/2025 09:41
Double Digit IRR Likely With Avid Bioservices
Seeking Alpha · 02/01/2025 15:05
Avid Bioservices Approves Merger with Space Finco
TipRanks · 01/30/2025 22:29
Avid Bioservices’ stockholders approve transaction with GHO and Ampersand
TipRanks · 01/30/2025 21:36
Avid Stockholders Approve Transaction with GHO and Ampersand
Barchart · 01/30/2025 15:05
Weekly Report: what happened at CDMO last week (0120-0124)?
Weekly Report · 01/27/2025 09:42
Catalyst Watch: Microsoft, Meta, and Tesla report, FOMC and a Chinese New Year wildcard
Seeking Alpha · 01/24/2025 20:00
Press Release: Avid Reminds Stockholders to Vote -2-
Dow Jones · 01/22/2025 21:05
Press Release: Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand
Dow Jones · 01/22/2025 21:05
Avid Bioservices says ISS, Glass Lewis recommend vote ‘FOR’ transaction
TipRanks · 01/21/2025 13:27
Press Release: Avid Recommends Stockholders -2-
Dow Jones · 01/21/2025 13:01
Press Release: Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand
Dow Jones · 01/21/2025 13:01
Weekly Report: what happened at CDMO last week (0113-0117)?
Weekly Report · 01/20/2025 09:39
Proxy adviser ISS said to recommend Avid Bioservices holders vote for takeover
Seeking Alpha · 01/17/2025 21:05
Laughing Water Capital Q4 2024 Letter
Seeking Alpha · 01/16/2025 12:50
More
Webull provides a variety of real-time CDMO stock news. You can receive the latest news about Avid Bioservices through multiple platforms. This information may help you make smarter investment decisions.
About CDMO
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.